• Accueil >
  • Publications >
  • Efficacy of Lorlatinib in Primary Crizotinib-Resistant Adult Neuroblastoma Harboring ALK Y1278S Mutation

Efficacy of Lorlatinib in Primary Crizotinib-Resistant Adult Neuroblastoma Harboring ALK Y1278S Mutation

1 déc. 2019JCO Precision Oncology

DOI : 10.1200/po.18.00396

Auteurs

Antoine Vasseur, Luc Cabel, Romain Geiss, Gudrun Schleiermacher, Gaëlle Pierron, Maud Kamal, Nina Jehanno, Guillaume Bataillon, Jean-Marc Guinebretiere, Laurence Bozec